Target intelligence / Profile preview

Reactive oxygen species and redox-related pathways (ROS/Redox pathways)

Target
ROS/Redox pathways
Molecular classification
Other
01

Overview

Reactive oxygen species (ROS) and redox-related pathways encompass the biochemical processes involved in the generation, signaling, and neutralization of oxygen-derived molecules such as superoxide and hydrogen peroxide (NIH, 2015). In physiological conditions, ROS act as vital secondary messengers that regulate cell growth, differentiation, and immune responses (Antioxid. Redox Signal., 2015). However, an imbalance between ROS production and the body's antioxidant capacity—termed oxidative stress—leads to macromolecular damage to DNA, proteins, and lipids, contributing to the pathogenesis of cancer, neurodegeneration, and cardiovascular diseases (J. Clin. Invest., 2026). Therapeutic strategies focus on restoring redox homeostasis by either neutralizing excess ROS with antioxidants or enhancing endogenous defenses through Nrf2 activation (NIH, 2026). Despite their potential, targeting these pathways is challenging because ROS are essential for normal signaling, and global suppression can lead to unintended side effects or even promote disease progression in certain contexts (ResearchGate, 2026). Biomarkers such as 8-hydroxy-2'-deoxyguanosine and malondialdehyde are commonly used to monitor oxidative damage and treatment efficacy (ACS, 2015).

Other names
Oxidative stress pathwaysRedox signalingROS metabolismRedox homeostasisReactive oxygen species signaling
02

Mechanism of action

Modulation of redox balance through direct antioxidant scavenging, activation of the Nrf2-Keap1 antioxidant response pathway, or pharmacological inhibition of ROS-generating enzymes such as NADPH oxidases (NOX), xanthine oxidase (XO), and monoamine oxidase (MAO).

03

Biological functions

Signal transductionApoptosisCell proliferationImmune responseMetabolismAutophagyGene expression regulation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetesAgingIschemia-reperfusion injury
05

Safety considerations

Interference with essential physiological ROS signalingPotential to promote tumor survival in established cancersAntioxidant paradox (excessive antioxidants causing harm)Lack of specificity for disease-relevant ROS sourcesOff-target effects of enzyme inhibitors
06

Interacting drugs

N-acetylcysteine

7 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Glutathione (GSH/GSSG) ratioProtein carbonylsIsoprostanes4-hydroxynonenal (4-HNE)

Beyond the preview

Go deeper on Reactive oxygen species and redox-related pathways (ROS/Redox pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and redox-related pathways (ROS/Redox pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call